Search - tctmd.com

Displaying 1 - 20 of 153

Sort: Relevancy | Date

News Daily News

Evolocumab Wins for Primary Prevention in VESALIUS-CV

L.A. McKeown

October 03, 2025

News Daily News

Heart Disease Treatment Costs $100 Billion per Year in the US

L.A. McKeown

July 30, 2025

News Daily News

FDA Approves First ‘Near-Complete’ Stabilizer to Treat ATTR Cardiomyopathy

L.A. McKeown

November 25, 2024

News Daily News

AHA Statement Outlines Cardiac Contributions to Brain Health

L.A. McKeown

October 11, 2024

News Daily News

Scoring System Puts Focus on Medical Therapy Optimization in HFrEF

L.A. McKeown

August 13, 2024

News Daily News

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

L.A. McKeown

July 02, 2024

News Daily News

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

L.A. McKeown

June 05, 2024

News Daily News

First Drugs Chosen for Medicare Negotiations Hit Close to Home for Cardiologists

L.A. McKeown

August 31, 2023

News Daily News

TCTMD’s Michael O’Riordan Wins Digital Health Award

Shelley Wood

August 22, 2023

News Daily News

Statin Therapy Still Lacking for Many US Patients With ASCVD

L.A. McKeown

August 07, 2023

News Daily News

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

L.A. McKeown

July 11, 2023

News Daily News

Maternal CV Risk After Adverse Pregnancy Outcome Can Last Over 40 Years

L.A. McKeown

February 13, 2023

News Daily News

Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis

L.A. McKeown

February 02, 2023

News Daily News

Shifting Acute MI Outcomes by Medicare Type: A Window Into Insurer’s Influence

L.A. McKeown

December 09, 2022

News Daily News

Upping Generic CV Drug Scripts Could Save Medicare and Patients Millions

L.A. McKeown

December 17, 2021

News Daily News

Discharge Safe as Early as a Day After Primary PCI for STEMI

L.A. McKeown

December 15, 2021

News Daily News

Statins Underprescribed in PAD Before and After Interventions

L.A. McKeown

December 03, 2021

News Daily News

CVD Risk ‘Underappreciated’ After Adverse Pregnancy Outcomes

L.A. McKeown

November 01, 2021

News Daily News

Making the Case for Sex-Specific CVD Guidelines

L.A. McKeown

July 08, 2021

News Daily News

It Pays to Reward Doctors for Risk-Stratifying Patients, Early Data Hint

L.A. McKeown

June 04, 2021

Advertisement

Evolocumab Wins for Primary Prevention in VESALIUS-CV

Heart Disease Treatment Costs $100 Billion per Year in the US

FDA Approves First ‘Near-Complete’ Stabilizer to Treat ATTR Cardiomyopathy

AHA Statement Outlines Cardiac Contributions to Brain Health

Scoring System Puts Focus on Medical Therapy Optimization in HFrEF

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

First Drugs Chosen for Medicare Negotiations Hit Close to Home for Cardiologists

TCTMD’s Michael O’Riordan Wins Digital Health Award

Statin Therapy Still Lacking for Many US Patients With ASCVD

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

Maternal CV Risk After Adverse Pregnancy Outcome Can Last Over 40 Years

Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis

Shifting Acute MI Outcomes by Medicare Type: A Window Into Insurer’s Influence

Upping Generic CV Drug Scripts Could Save Medicare and Patients Millions

Discharge Safe as Early as a Day After Primary PCI for STEMI

Statins Underprescribed in PAD Before and After Interventions

CVD Risk ‘Underappreciated’ After Adverse Pregnancy Outcomes

Making the Case for Sex-Specific CVD Guidelines

It Pays to Reward Doctors for Risk-Stratifying Patients, Early Data Hint

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content